Statin safety comparison
Pro Research Analysisby 
Searched over 200M research papers
Statin Safety: General Overview and Class Effects
Statins are widely used to lower cholesterol and reduce cardiovascular risk. Overall, statins are considered safe, with serious adverse events being rare. The risk of severe muscle injury (like rhabdomyolysis) is less than 0.1%, and serious liver toxicity is extremely uncommon, at about 0.001% per year. Statins do slightly increase the risk of new-onset diabetes (about 0.2% per year), and may cause mild increases in liver enzymes and muscle symptoms, but these are generally not severe or common enough to outweigh the cardiovascular benefits of statin therapy Naci2013Newman2019Adhyaru2018+1 MORE.
Comparative Safety of Individual Statins
When comparing individual statins, some differences in safety and tolerability have been observed. Simvastatin and pravastatin tend to be safer and more tolerable than other statins, with fewer adverse events and discontinuations. Atorvastatin and rosuvastatin, while highly effective at lowering cholesterol, are associated with a higher risk of discontinuation and liver enzyme elevations at higher doses. High-dose simvastatin is linked to an increased risk of creatine kinase elevation, a marker of muscle injury Naci2013Yebyo2019.
In Asian populations, pitavastatin appears to have a lower risk of safety events, such as hepatitis and new-onset diabetes, compared to atorvastatin and rosuvastatin .
Muscle Safety and Tolerability
Statins as a class are associated with only a slight increase in muscle symptoms compared to placebo. There are no significant differences between individual statins in the risk of muscle symptoms, myalgia, myopathy, or rhabdomyolysis. However, moderate doses of simvastatin and pravastatin may have a higher risk of significant creatine kinase elevation compared to moderate-dose atorvastatin. Lipophilic statins and those metabolized by liver enzyme CYP3A4 do not show increased muscle risk Hou2022Newman2019Bolego2002.
Hepatic and Renal Safety
Statins can cause mild, reversible increases in liver enzymes, especially at higher doses. Atorvastatin, rosuvastatin, fluvastatin, lovastatin, and simvastatin at higher doses are more likely to cause these elevations. Statins are associated with a lower risk of serious adverse effects and less elevation in serum creatinine compared to fibrates, but may cause more mild liver enzyme elevations Naci2013Yebyo2019Blais2021.
Special Populations: Older Adults and HIV-Positive Patients
Statins are effective and safe in older adults, with benefits outweighing risks across age groups . In HIV-positive patients, statins (especially rosuvastatin and atorvastatin) are effective at lowering cholesterol and are generally well tolerated when doses are adjusted for drug interactions with antiretroviral therapy .
Statins vs. Fibrates
Compared to fibrates, statins have a lower risk of serious adverse effects and kidney-related side effects, but a slightly higher risk of mild liver enzyme elevations. The risk of muscle pain (myalgia) is similar between the two drug classes .
Conclusion
Statins are generally safe, with serious adverse events being rare. Simvastatin and pravastatin are among the safest and most tolerable, while atorvastatin and rosuvastatin are highly effective but may have higher risks at high doses. Pitavastatin may be safer in Asian populations. Muscle and liver side effects are usually mild and uncommon, and the benefits of statin therapy in reducing cardiovascular events far outweigh the risks for most patients Naci2013Hou2022Lin2021+6 MORE.
Sources and full results
Most relevant research papers on this topic